![Charmaine Gittleson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charmaine Gittleson
Chairman at
PERCHERON THERAPEUTICS LIMITED
Net worth: 5 125 $ as of 30/06/2026
Profile
Charmaine Gittleson is Non-Executive Chairman at Percheron Therapeutics Ltd. since 2023, Independent Non-Executive Director at Polynovo Ltd. starting 2026, Non-Executive Director at George Medicines Pty Ltd., and Non-Executive Director at Imugene Ltd. starting 2026.
Former roles include Chairman at Patrys Ltd. from 2022 to 2025 and Chief Medical Officer at CSL Ltd. Education includes an undergraduate degree from the University of the Witwatersrand.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/12/2024 | 2,464,000 ( 0.16% ) | 5 125 $ | 30/06/2026 |
Charmaine Gittleson active positions
| Companies | Position | Start |
|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Chairman | - |
| POLYNOVO LIMITED | Director/Board Member | 01/04/2026 |
| IMUGENE LIMITED | Director/Board Member | 30/06/2026 |
Former positions of Charmaine Gittleson
| Companies | Position | End |
|---|---|---|
| PATRYS LIMITED | Chairman | 17/06/2025 |
| CSL LIMITED | Chief Tech/Sci/R&D Officer | - |
Training of Charmaine Gittleson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
14
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Percheron Therapeutics Ltd.
 Percheron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes antisense pharmaceuticals | Health Technology |
Patrys Ltd.
 Patrys Ltd. Pharmaceuticals: MajorHealth Technology Develops novel antibody technologies for hard-to-treat cancers | Health Technology |
Imugene Ltd.
 Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
Polynovo Ltd.
 Polynovo Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Charmaine Gittleson
